...
首页> 外文期刊>Microbial Pathogenesis >Sublichenin, a new subtilin-like lantibiotics of probiotic bacterium Bacillus licheniformis MCC 2512(T) with antibacterial activity
【24h】

Sublichenin, a new subtilin-like lantibiotics of probiotic bacterium Bacillus licheniformis MCC 2512(T) with antibacterial activity

机译:Sublichenin,一种益生菌菌芽孢杆菌的新的亚芽杆菌样Lantibiotics,具有抗菌活性的MCC 2512(T)

获取原文
获取原文并翻译 | 示例
           

摘要

Probiotic bacteria with antibacterial activity is of desirable trait since they can check the growth of pathogenic bacteria besides exhibiting health benefits to host. Aim of this study was to characterize Bacillus licheniformis MCC 2512(T) (MCC 2512), a potential probiotic culture for its ability to produce subtilin-like antibiotics. The anti-microbial compound produced by MCC 2512 was identified and characterized using subtilin-specific cell reporter, Bacillus subtilis 168:BS2 (BS2). Induction of beta-gal by the test culture suggested the ability of B. licheniformis to produce subtilin-like lantibiotic. Subsequently, DNA sequencing of major lanS-operon was carried out, wherein sequencing results showed that lan cluster of MCC 2512 resembles entianin (etn) type. Upon Lan-S disruption, the bacterial culture lost antimicrobial activity as well as ability to induce beta-gal with BS2 reporter. High amount of succinylated form of antibiotics produced by wild type and un-succinylated form by engineered strain of B. subtilis 15029p clearly indicates that MCC 2512 is indeed an inter-specific subtilin-like (named as sublichenin) lantibiotic producer. Partially concentrated sublichenin preparation exhibited strong antibacterial activity against food-borne pathogens and antibiotic resistant (AR) lactic acid bacteria (LAB) with a minimum inhibitory concentration in the range of 6-10 and 0.5-1.5 mu g/ml, respectively. Production of lantibiotic, sublichenin by a probiotic bacterium of B. licheniformis MCC 2512(T) and its antibacterial activity against food associated AR LAB is a new information reported in this study.
机译:具有抗菌活性的益生菌属于特征,因为它们可以检查病原细菌的生长,除了表现出对宿主的健康益处。本研究的目的是表征芽孢杆菌的芽孢杆菌2512(T)(MCC 2512),潜在的益生菌培养物,用于产生亚枯霉素样抗生素的能力。使用MCC 2512产生的抗微生物化合物,并使用枯草杆菌细胞报告器,枯草芽孢杆菌枯草芽孢杆菌168:BS2(BS2)。测试培养物的诱导β-加仑表明B. licheniformis产生亚芽杆菌样叶绿素的能力。随后,进行主兰氏术的DNA测序,其中测序结果表明,MCC 2512的LAN群集类似于敌人(ETN)类型。在兰氏破坏后,细菌培养物失去了抗菌活性以及用BS2报告诱导β1Al的能力。通过B.枯草芽孢杆菌15029p的工程菌株通过野生型和未琥珀酰化形式产生的大量琥珀酰化形式的抗生素,明确表明MCC 2512确实是一种特异性枯草芽孢杆蛋白样(被命名为索米霉素)的扁麻菌药生产商。部分浓缩的Sublichenin制剂表现出对食物传播病原体和抗生素抗菌(AR)乳酸菌(实验室)的强抗菌活性,其最小抑制浓度分别为6-10和0.5-1.5μg/ ml。通过B.Licheniformis MCC 2512(T)的益生菌细菌的Lantibiotic,Sublichenin的生产及其针对食物相关AR实验室的抗菌活性是本研究报告的新信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号